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Introduction 
Axillary lymph node status remains an important
prognostic indicator for women with breast cancer and
axillary dissection provides accurate information re-
garding nodal status. Local control of axillary disease
and decision about adjuvant systemic therapy are de-
pendent on appropriate axillary surgery. Sentinel
lymph node biopsy (SLNB) has become an important
staging procedure,however, is not yet considered the
standard of care for all breast cancer cases and axillary
node-positive disease still requires adequate local con-
trol and accurate staging information. Axillary clearance
is indicated for women with a clinically positive axil-
la and women who are subsequently found to be po-
sitive following sentinel node biopsy. Many studies
showed that from 10 to 20% of women with a clini-
cally negative axilla, and a primary tumour that was >20
mm and had vessel invasion, had level III axillary me-
tastases. If sentinel node biopsy is validated as an axil-
lary staging procedure for breast cancer, women with
a positive sentinel node may still require further axil-
lary surgery. The morbidity of adding a level III dis-
section to a level I and II dissection is poorly quanti-
fied from the published works. The technique is de-
scribed for complete axillary clearance that includes no-
des of levels I–III. In our experience, this technique is
associated with no additional morbidity and involves
only minimal extension of operative time. 
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The new staging technique of sentinel node biopsy facilitates the
identification of pathological node negative patients in whom axillary
dissection may be avoided; however, patients with a positive sentinel
node biopsy would require a thorough examination of their nodal sta-
tus. Axillary dissection provides good local control, accurate staging and
prognostic information for decisions about adjuvant therapy. We de-
scribe a technique of radical axillary clearance that includes levels I, II
and III; this isn’t associated with additional morbidity to patients and
involres minimal extension of operative time. 
RIASSUNTO: La linfectomia ascellare radicale nell’era del linfono-
do sentinella: è ancora importante nel trattamento del carcinoma
mammario?
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La chirurgia del cancro della mammella è sempre più conservati-
va. La biopsia del linfonodo sentinella facilita notevolmente questo at-
teggiamento.Le pazienti linfonodo sentinella-positive necessitano co-
munque della linfectomia ascellare per stadiazione. Ciò garantisce un
buon controllo locale della malattia e indicazioni prognostiche per il
trattamento adiuvante. Descriviamo la tecnica della linfectomia ascel-
lare radicale comprendente il III livello. Tale metodica ha una serie di
complicanze sovrapponibili alla linfectomia di I e II livello ed i tempi
operatori risultano minimamente allungati.
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Procedure  
With the patient in the supine position, the lateral chest wall is
placed level with the edge of the table. The arm is  placed on an arm
board, abducted to 90°. A curved incision, convex upward, is made
just below the hairbearing area of the axilla. The limits of incision
are the anterior and posterior axillary folds and a better cosmetic re-
sult is obtained if these are not crossed. The axillary dissection can
be carried out in conjunction with an upper outer quadrantectomy
but the surface boundaries of the axilla should be similarly respec-
ted. A radial incision does not need to extend beyond a point level
with the lower margin of the hairbearing area.
Access in the axilla. Initially, raising an upper and lower skin
flap,approximately 3 cm, improves access. Dissection is continued
anteriorly and medially behind the anterior axillary fold to the la-
teral margin of pectoralis major. The axillary contents are then freed
from the pectoralis major muscle and the more deeply situated pec-
toralis minor muscle. The lateral margin of this one is easily identi-
fied as its muscle bundles run craniocaudally in relation to the tran-
sversely running fibres of serratus anterior. The lateral chest wall, co-
vered by serratus anterior, can then be followed from before
backward until the craniocaudally running anterior muscle fibres of
latissimus dorsi are seen. This most caudal extent of the dissection
is approximately at the fourth thoracic vertebral level. The lateral mu-
scle edge of latissimus dorsi marks the lateral extent of the dissection. 
Searching the nerves. The lower branch of the intercostobrachial
nerve will be found crossing this edge higher up and can be preser-
ved at this point. It is necessary to incise the investing axillary fascia
in a direction parallel to the edge of latissimus dorsi. The subscapular
vessels and thoracodorsal nerve may be identified with a dissection
worked out with ultrasound scissors. These structures remain
bound to the muscle by fascia 2 cm from its lateral margin. In its lower
extent the nerve is in close relation with the vessels and take an an-
gled course in the vicinity of the angular vein. Lateral intercostal ves-
sels join the subscapular vessels. These can be followed back to the
chest wall and are as a reliable landmark for locating the long tho-
racic nerve. Establishing a plane of dissection without breaching this
fascial layer minimizes the risk of injury to the nerve as the surgery
proceeds cephalad. This straight forward dissection can be continued
almost to the level of the axillary vein. The first structure that is seen
well forward of the mid-axillary line is the intercostobrachial nerve.
This structure can be preserved by following it and dividing the axil-
lary contents until the lateral border of latissimus dorsi is seen. If no-
dal involvement is suspected then disruption of the axillary contents
is best avoided and the nerve sacrificed. There is a gutter between the
long thoracic nerve and the thoracodorsal nerve, both still attached
to the respective muscles of supply. 
Axillary vessels exposure. When the intercostobrachial nerve is
identified, the operator should be aware that the axillary vein is a 1
cm in a cranial direction. The infero lateral portion of the clavipec-
toral fascia at the upper extent of the dissection is readily seen. When
this is divided and the underlying fat gently teased away, the axillary
vein will be identified without difficulty. It is necessary to dissect ri-
ght along the inferior margin of the vein surface by dividing its in-
vesting fascia. By dragging this down with forceps the medial pec-
toral nerve is identified with the blood supply to pectoralis minor.
Often, a duplex axillary vein is seen. Another anomaly that may con-
fuse at this point is a congenital muscular, occasionally tendinous,
band crossing the axillary vein. It’s known as ‘Langer’s Arch’ and it’s
occur in approximately 1 in 400 cases. 
Level II and III dissection. Incision of the fascia on the poste-
rior aspect of pectoralis minor allows the insertion of a large  retrac-
tor. The pectoral muscles can then be lifted up and away from the che-
st wall. The highest lateral intercostal vessels will need to be divided
against the chest wall to facilitate access to the level III nodes. As the
inferior margin of the axillary vein is followed, the lateral thoracic tri-
butaries and any other small tributaries are ligated and divided in suc-
cession. The acromiothoracic tributaries at the highest level of dissection
must be handled very carefully. The dissection ends where the ten-
don of subclavius is seen. A small gauze swab left in the apex for a few
minutes will control any minor ooze that may occurs. With blunt dis-
section between the pectoralis major and minor muscles, any inter-
pectoral nodes can be identified and removed. The lateral pectoral ner-
ve and acromiothoracic vessels perforate the fascia and care must be
taken not to injure these structures or the lateral pectoral branches
situated in the interpectoral space.  After the axillary dissection has
been completed, a suction drain inserted, wound is closed. A pres-
sure dressing is then applied to the axilla. Those are removed 24 h af-
ter surgery and patient may be discharged from hospital.
Discussion
The principal roles of axillary dissection are eradication
of metastatic disease in the axillary nodes, and deter-
mination of nodal status to evaluate prognosis and fa-
cilitate decisions about adjuvant therapy. However, the
question of whether, and to what extent, ALN should
be removed for patients with operable breast cancer is
yet to be conclusively answered. 
The technique of sentinel node biopsy is emerging as
a well known alternative to axillary dissection; however,
clinicians would still be faced with the need to perform
more extensive axillary surgery for women with a positi-
ve SNB.  Prognosis is also related to the number of involved
nodes. Fisher reported a 5-year disease-free survival of 60%
for patients with 1-3 positive nodes, and 31% for those
with ≥ 4 positive nodes. Accurate determination of the ex-
tent of nodal involvement is also required to estimate the
risk of local-regional recurrence and enable decisions about
adjuvant radiation therapy. There is consensus that wo-
men with ≥4 positive axillary nodes should receive post-
mastectomy radiation to improve local-regional control.
A level III axillary dissection provides optimal staging infor-
mation, both qualitative (positive or negative) and quan-
titative (number of involved nodes), for assessing prognosis
and predicating further therapeutic interventions. Ana-
tomically, of the three axillary levels, the greatest volume
of tissue and number of lymph nodes lie in level I. Level
II is an area bound by the chest wall posteriorly, the pec-
toralis minor anteriorly and on either side, is defined by
the medial and lateral borders of this muscle. The muscle
is applied closely to the chest wall and is narrow as it ta-
pers towards its point of insertion at the coracoid process.
After a dissection has been carried out up to level II using
the technique described, further surgery to incorporate le-
vel III nodes involves only approximately another 10 min
of operating time; and, no new planes are traversed to com-
plete the axillary clearance. 
There is no evidence to suggest from an anatomical
point of view that an axillary clearance carried out in this
manner leads  higher morbidity. It would be reasonable
to expect that disruption of the natural anatomical pla-
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nes of the axilla during surgery may result in a higher in-
cidence of lymphoedema. Dissection respecting the boun-
daries described need not necessarily lead to more
morbidity. Although there is good evidence that low-le-
vel sampling is associated with less morbidity, this may
not be adequate local surgery for node-positive disease.
The ability to identify the ‘positive’ axilla with sentinel
node techniques, magnetic resonance imaging or posi-
tron emission tomography scanning, continues to im-
prove. Therefore, the importance of an oncological ope-
ration that maximizes local control and prognostic infor-
mation is paramount.
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